Bioequivalence clinical trial of two formulations of edoxaban.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510795-20-00

Acronym

N-EDO-24-285

Enrollment

Registered

2024-05-14

Start date

2024-06-11

Completion date

2024-07-30

Last updated

2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026